Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2011-01-25 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROMORANTIN-LANTHENAY (41200), Loir-et-Cher
PHARMACIE CLOS DE L'ARCHE : revenue, balance sheet and financial ratios
PHARMACIE CLOS DE L'ARCHE is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROMORANTIN-LANTHENAY (41200),
this company of category PME
shows in 2024 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CLOS DE L'ARCHE (SIREN 529833303)
Indicator
2025
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 988 060 €
1 808 240 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
140 643 €
150 569 €
136 538 €
239 599 €
59 946 €
102 539 €
129 103 €
161 421 €
115 619 €
EBITDA
N/C
246 880 €
203 384 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
7.6%
7.6%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE CLOS DE L'ARCHE generates positive net income of 141 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 116 k€ -> 141 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
140 643 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 21%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
21.154%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.036%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CLOS DE L'ARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Debt ratio
148.663
111.88
85.499
57.632
34.845
27.501
27.999
27.268
21.154
Financial autonomy
36.684
44.195
48.895
58.997
66.913
68.442
71.305
69.858
74.036
Repayment capacity
None
None
None
None
None
None
2.446
2.076
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
9.596%
9.882%
None%
Sector positioning
Debt ratio
21.152025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE CLOS DE L'ARCHE (21.15) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
74.04%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent
In 2025, the financial autonomy of PHARMACIE CLOS DE L'ARCHE (74.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
2.08 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Good
In 2024, the repayment capacity of PHARMACIE CLOS DE L'ARCHE (2.08) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 272.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
272.592
Liquidity indicators evolution PHARMACIE CLOS DE L'ARCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Liquidity ratio
325.176
487.674
364.055
400.247
234.944
232.603
311.834
266.825
272.592
Interest coverage
None
None
None
None
None
None
3.282
1.757
None
Sector positioning
Liquidity ratio
272.592025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE CLOS DE L'ARCHE (272.59) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.76x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average-10 pts over 2 years
In 2024, the interest coverage of PHARMACIE CLOS DE L'ARCHE (1.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CLOS DE L'ARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
340 040 €
288 965 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
57
58
0
Customer payment term (days)
0
0
0
0
0
0
5
3
0
Supplier payment term (days)
0
0
0
0
0
0
37
43
0
Positioning of PHARMACIE CLOS DE L'ARCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE CLOS DE L'ARCHE is estimated at
2 234 130 €
(range 1 516 091€ - 3 505 658€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1516k€2234k€3505k€
2 234 130 €Range: 1 516 091€ - 3 505 658€
NAF 5 année 2025
Valuation method used
Net Income Multiple
140 643 €
×
15.9x
=2 234 131 €
Range: 1 516 092€ - 3 505 659€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CLOS DE L'ARCHE with other companies in the same sector:
Frequently asked questions about PHARMACIE CLOS DE L'ARCHE
What is the revenue of PHARMACIE CLOS DE L'ARCHE ?
The revenue of PHARMACIE CLOS DE L'ARCHE in 2024 is 2.0 M€.
Is PHARMACIE CLOS DE L'ARCHE profitable?
Yes, PHARMACIE CLOS DE L'ARCHE generated a net profit of 141 k€ in 2025.
Where is the headquarters of PHARMACIE CLOS DE L'ARCHE ?
The headquarters of PHARMACIE CLOS DE L'ARCHE is located in ROMORANTIN-LANTHENAY (41200), in the department Loir-et-Cher.
Where to find the tax return of PHARMACIE CLOS DE L'ARCHE ?
The tax return of PHARMACIE CLOS DE L'ARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CLOS DE L'ARCHE operate?
PHARMACIE CLOS DE L'ARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart